Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Moderna

FDA approves updated Moderna and Pfizer Covid boosters set to arrive soon as cases rise: Latest

An updated Coronavirus booster that targets a new variant is expected to be made available in September

The Independent UK

Jets' Aaron Rodgers shows support for unvaccinated tennis star Novak Djokovic

Aaron Rodgers crossed an item off his sports bucket list and then made a statement with a more visible crossout

The Independent UK

New Covid variant ‘Pirola’ sparks case rise across US and Canada as Moderna shares vaccine update – latest

An updated Coronavirus booster that targets a new variant is expected to be made available in September

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Former Covid medical officer Van-Tam takes role at vaccine maker Moderna

One of UK’s public faces of pandemic, ‘JVT’ was known for football-related metaphors in No 10 briefings

The Guardian - UK

Covid booster jabs could go on sale privately in UK in 2024

Health officials reiterate support for private provision as lower age limit for NHS booster vaccines raised to 65

The Guardian - UK

Ex-medical chief Jonathan Van-Tam takes job with Covid vaccine giant Moderna

Move may spark fresh questions over ‘revolving door’ between government and business

The Independent UK

When Should You Get Your Next Covid-19 Booster? There’s One Easy Answer To This Question

Vaccine manufacturers like Pfizer/BioNTech, Moderna, and Novavax are switching up their shots in preparation for the new season.

Inverse

Read news from The Economist, FT, and more,
with one subscription

Covid vaccines should be available to buy privately in UK, scientists say

People not eligible for autumn booster programme should have option to pay for jab, experts argue, amid new wave concerns

The Guardian - UK

Coronavirus FAQ: Is it wiser to get a booster now or wait for the new fall booster?

Maybe it's not a full-blown summer surge but COVID numbers are ticking up. For those with concerns due to personal risk factors or the start of the school year, the booster question is top of mind.

WEKU

For Flagship, Moderna’s COVID-19 vaccine is a tough act to follow

Unorthodox, brash, and sometimes controversial, Flagship Pioneering is looking for its next blockbuster.

Fortune

The Most Objective Evidence Shows No Indication That Covid Vaccines Save More Lives Than They Take

Medical journals describe all-cause mortality in randomized controlled trials (RCTs)

Zenger

FDA Violated Own Safety And Efficacy Standards In Approving Covid-19 Vaccines For Children

Evidence the FDA used for those decisions violates at least three safety and efficacy standards from earlier FDA publications

Zenger

Pfizer and Moderna parent are investing $100M to find the next big drug

"What we are doing now, I don’t think anyone has done so far," Pfizer CEO Albert Bourla says.

Fortune

Moderna signs deal to make mRNA vaccines for Chinese market

Moderna Inc. will push toward producing messenger RNA vaccines for China, seeking a foothold in the world’s second-largest pharmaceutical market even as geopolitical tensions rise.

Tribune News Service

Get all your
news in one place.

100's of premium titles.
One news app.

Inverse

A Long-Awaited Vaccine For Lyme Disease is Tantalizingly Close — Here's When It Could Be Available

Over the past twenty years, Lyme disease cases have continued to climb, and we are finally tantalizingly close to another vaccine.

The Guardian - UK

UK regulator sued for not investigating Covid vaccine ‘misinformation’

Case brought against General Medical Council for failure to look into claimed links to heart problems and deaths

Fortune

Health care providers are adding cloud tech, but need to dream bigger

Currently, the application of cloud in the health care space is choppy.

Fortune

Cancer vaccines are already a reality. Here's what you need to know about the cutting-edge technology that could usher in an era of personalized medicine

The concept may seem torn from the plot of some futuristic sci-fi movie, or from the pages of some decades-old utopian novel far ahead of its time. But such wonders of science exist today.

Get all your
news in one place.

100's of premium titles.
One news app.

Zenger

Moderna Stock Rises After FDA Application For Updated Vaccine

Moderna's potential beyond COVID-19 is underappreciated, says analyst Eliana Merle, who upgraded the stock to Buy

StockNews.com

Moderna (MRNA) vs. BioNTech (BNTX): Which Biotech Stock Should You Be Investing In?

Amidst the biotech industry’s rapid growth and notable advancements, let’s analyze which of the two major players, Moderna (MRNA) and BioNTech (BNTX), is a more favorable investment choice in the current uncertain economic climate. Keep reading to find out.

Inverse

mRNA Vaccines Could Revolutionize Cancer Treatment

Here’s a look at the status of mRNA technology's application in cancer and when it might reach patients.

Wales Online

Devastating virus few parents know about hits three babies a day

World-first vaccine trials have now begun in a bid to protect children from CMV

Insider UK

Scottish Mortgage sees share price fall by a third

Net asset value also fell by more than 17% during a year that has been 'painful for shareholders'

Inverse

These Next-Generation Vaccines Could Upend Cancer Treatment As We Know It

New high-tech vaccines could help combat common yet deadly conditions like cancer and heart disease.

The Walrus

The Vaccine Problem

To better weather future pandemics, the way countries procure vaccines needs to change radically

1 … 10 11 12 13

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Centers for Disease Control and Prevention

226 stories

MRNA

219 stories

the Food and Drug Administration

214 stories

Novavax

209 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.